Bell Investment Advisors »

Allogene Therapeutics shares owned by Bell Investment Advisors

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Bell Investment Advisors from 13F filings

Historical chart of Bell Investment Advisors investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Bell Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Bell Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $719 161 4.47
2023-12-31 $517 161 3.21
2021-09-30 $2.0k 88 22.73

More positions owned by Bell Investment Advisors

Goldman Sachs Etf Tr Acces Treasury (GBIL)
Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Flexshares Tr Iboxx 3r Targt (TDTT)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Schwab Strategic Tr Schwab Fdt Us Sc (FNDA)
Ishares Tr Msci Usa Mmentm (MTUM)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Ishares Tr Core S&p Scp Etf (IJR)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Bell Investment Advisors

Top funds holding Allogene Therapeutics

Tpg Gp A
Vanguard Group
Jpmorgan Chase & Co
PRIMECAP Management Company
Citadel Advisors
Goldman Sachs Group
T. Rowe Price Associates
Two Sigma Investments
Millennium Management
Vida Ventures Advisors
Dimensional Fund Advisors
Two Sigma Advisers
Charles Schwab Investment Management
Caxton Associates
Nordea Investment Management Ab

View all funds holding Allogene Therapeutics